Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

sun pharmaceutical industries (europe) b.v. - cetirizina - cetirizina

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

sun pharmaceutical industries (europe) b.v. - acido alendronico - acido alendronico

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

sun pharmaceutical industries (europe) b.v. - meropenem - meropenem

Europeiska unionen - italienska - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sonidegib difosfato - carcinoma, cellule basali - agenti antineoplastici - odomzo è indicato per il trattamento di pazienti adulti con carcinoma basocellulare localmente avanzato (bcc) che non sono suscettibili di chirurgia curativa o radioterapia.

Europeiska unionen - italienska - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

sun pharmaceutical industries (europe) b.v. - ceftriaxone - ceftriaxone

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

sun pharmaceutical industries (europe) b.v. - pantoprazolo - pantoprazolo

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

sun pharmaceutical industries (europe) b.v. - simvastatina - simvastatina

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

sun pharma italia srl - ranitidina - ranitidina

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

sun pharmaceutical industries (europe) b.v. - ranitidina - ranitidina